These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 14011382)
1. Clinical experience with sulphonylureas. AHUJA MM J Indian Med Assoc; 1962 Sep; 39():221-8. PubMed ID: 14011382 [No Abstract] [Full Text] [Related]
2. Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus. BOSHELL BR; WILENSKY AS; BARRETT JC; ALMON JV Clin Pharmacol Ther; 1962; 3():750-7. PubMed ID: 14014164 [No Abstract] [Full Text] [Related]
3. THE ACTION OF SULFONYLUREAS IN PRODUCING HYPOGLYCEMIA. WILENSKY AS Ala J Med Sci; 1964 Jan; 1():83-91. PubMed ID: 14192740 [No Abstract] [Full Text] [Related]
4. HYPOGLYCEMIC COMA DURING SULFONYLUREA THERAPY. BERGMAN H Acta Med Scand; 1965 Mar; 177():287-98. PubMed ID: 14281786 [No Abstract] [Full Text] [Related]
5. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE]. KLINGER R; DALLECOSTE P Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829 [No Abstract] [Full Text] [Related]
6. CORNEAL AND LENTICULAR OPACITIES IN THE EYES OF RATS FOLLOWING LONG-TERM ADMINISTRATION OF SULFONYLUREA DERIVATIVES. A PRELIMINARY REPORT. WRIGHT HN Diabetes; 1963; 12():550-4. PubMed ID: 14075328 [No Abstract] [Full Text] [Related]
7. A REVIEW OF THE HISTORY OF THE TREATMENT OF DIABETES MELLITUS AND THE SEARCH FOR ORAL HYPOGLYCAEMIC AGENTS. PADFIELD CJ Guys Hosp Rep; 1964; 113():45-54. PubMed ID: 14114729 [No Abstract] [Full Text] [Related]
8. [SIDE-EFFECTS IN THE ORAL TREATMENT OF DIABETES WITH SULFONYLUREAS]. OSTMAN J; GROENBERG A Nord Med; 1964 Nov; 72():1388-95. PubMed ID: 14210083 [No Abstract] [Full Text] [Related]
9. [CONTRIBUTION TO THE STUDY OF THE TOXIC EFFECTS DUE TO HYPOGLYCEMIC SULFONYLUREAS]. CIAMMAICHELLA A; CANTERA N Minerva Med; 1964 Mar; 55():657-64. PubMed ID: 14140236 [No Abstract] [Full Text] [Related]
10. Clinical experiences with chlorpropamide, with special reference to comparison with previous experience with carbutamide and tolbutamide. HEINSEN HA Ann N Y Acad Sci; 1959 Mar; 74(3):709-16. PubMed ID: 13637612 [No Abstract] [Full Text] [Related]
11. Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin. Müller WE; Wollert U Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):551-4. PubMed ID: 819976 [No Abstract] [Full Text] [Related]
12. Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets. Hellman B; Sehlin J; Täljedal IB Acta Endocrinol (Copenh); 1984 Mar; 105(3):385-90. PubMed ID: 6230850 [TBL] [Abstract][Full Text] [Related]
13. Tolbutamide and chlorpropamide during pregnancy in human diabetics. JACKSON WP; CAMPBELL GD; NOTELOVITZ M; BLUMSOHN D Diabetes; 1962; 11(Suppl)():98-101. PubMed ID: 13964271 [No Abstract] [Full Text] [Related]
14. Complex formation between macromolecules and drugs. X. Binding of tolbutamide, chlorpropamide and carbutamide to human serum albumin, and the competition between tolbutamide or chlorpropamide and carbutamide or 4-sulfanilamido-2,6-dimethylpyrimidine for binding sites on human serum albumin. Nilsson B; Agren A Acta Pharm Suec; 1974 Sep; 11(4):391-400. PubMed ID: 4412551 [No Abstract] [Full Text] [Related]
15. [Behavior of the blood sugar and phosphorus levels during the glucose tolerance test before and after the administration of carbutamide, tolbutamide and chlorpropamide]. GIULIANO G; COLAJANNI L Boll Soc Ital Biol Sper; 1959 Dec; 35():1977-80. PubMed ID: 13828262 [No Abstract] [Full Text] [Related]
16. Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid. Hüthwohl B; Jähnchen E Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(3):204-12. PubMed ID: 4261772 [No Abstract] [Full Text] [Related]
17. A quantum chemical study with special reference to the sulfamyl group of sulfonylureas. Orita Y; Ando A; Takamitsu Y; Urakabe S; Shirai D Jpn Circ J; 1970 Sep; 34(9):775-8. PubMed ID: 5537674 [No Abstract] [Full Text] [Related]
18. [THE MECHANISM OF ACTION OF PERORAL ANTIDIABETICS]. HORN Z Bull Schweiz Akad Med Wiss; 1965 Feb; 21():67-76. PubMed ID: 14256856 [No Abstract] [Full Text] [Related]
19. [ORAL DIABETIC DRUGS]. POULSEN JE Nord Med; 1964 Feb; 71():243-5. PubMed ID: 14094587 [No Abstract] [Full Text] [Related]
20. [DIABETIC RETINOPATHY AND ITS TREATMENT]. DENEUMANN PS Arch Oftalmol B Aires; 1963 Jul; 38():207-18. PubMed ID: 14085250 [No Abstract] [Full Text] [Related] [Next] [New Search]